BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

747 related articles for article (PubMed ID: 25735814)

  • 21. [Effects of melittin on growth and angiogenesis of human hepatocellular carcinoma BEL-7402 cell xenografts in nude mice].
    Song CC; Lu X; Cheng BB; DU J; Li B; Ling CQ
    Ai Zheng; 2007 Dec; 26(12):1315-22. PubMed ID: 18076793
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Role and mechanism of nuclear factor kappa B in angiogenesis of human ovarian carcinoma].
    Yang LH; Wang KF; Zhou YP; Li ML
    Ai Zheng; 2004 May; 23(5):531-4. PubMed ID: 15142448
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HIF-1alpha-mediated up-regulation of vascular endothelial growth factor, independent of basic fibroblast growth factor, is important in the switch to the angiogenic phenotype during early tumorigenesis.
    Fang J; Yan L; Shing Y; Moses MA
    Cancer Res; 2001 Aug; 61(15):5731-5. PubMed ID: 11479208
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antitumor activities of a novel indolin-2-ketone compound, Z24: more potent inhibition on bFGF-induced angiogenesis and bcl-2 over-expressing cancer cells.
    Wang LL; Li JJ; Zheng ZB; Liu HY; Du GJ; Li S
    Eur J Pharmacol; 2004 Oct; 502(1-2):1-10. PubMed ID: 15464084
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Transcription factor Ets-1 regulates fibroblast growth factor-1-mediated angiogenesis in vivo: role of Ets-1 in the regulation of the PI3K/AKT/MMP-1 pathway.
    Forough R; Weylie B; Collins C; Parker JL; Zhu J; Barhoumi R; Watson DK
    J Vasc Res; 2006; 43(4):327-37. PubMed ID: 16682805
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gefitinib causes growth arrest and inhibition of metastasis in human chondrosarcoma cells.
    Song J; Zhu J; Zhao Q; Tian B
    J BUON; 2015; 20(3):894-901. PubMed ID: 26214645
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nobiletin, a citrus polymethoxyflavonoid, suppresses multiple angiogenesis-related endothelial cell functions and angiogenesis in vivo.
    Kunimasa K; Ikekita M; Sato M; Ohta T; Yamori Y; Ikeda M; Kuranuki S; Oikawa T
    Cancer Sci; 2010 Nov; 101(11):2462-9. PubMed ID: 20670297
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Magnolol suppresses hypoxia-induced angiogenesis via inhibition of HIF-1α/VEGF signaling pathway in human bladder cancer cells.
    Chen MC; Lee CF; Huang WH; Chou TC
    Biochem Pharmacol; 2013 May; 85(9):1278-87. PubMed ID: 23416116
    [TBL] [Abstract][Full Text] [Related]  

  • 29. IGF-I enhances α5β1 integrin expression and cell motility in human chondrosarcoma cells.
    Wu CM; Li TM; Hsu SF; Su YC; Kao ST; Fong YC; Tang CH
    J Cell Physiol; 2011 Dec; 226(12):3270-7. PubMed ID: 21344385
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The 18 kDa isoform of basic fibroblast growth factor is sufficient to stimulate human melanoma growth and angiogenesis.
    Fontijn D; Duyndam MC; Beliën JA; Gallegoz Ruiz MI; Pinedo HM; Boven E
    Melanoma Res; 2007 Jun; 17(3):155-68. PubMed ID: 17505261
    [TBL] [Abstract][Full Text] [Related]  

  • 31. FP3: a novel VEGF blocker with anti-angiogenic and anti-tumor effects.
    Gao W; Jin K; Lan H; Han N; Cao F; Teng L
    Hepatogastroenterology; 2012; 59(120):2543-7. PubMed ID: 22534543
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dual blockade of vascular endothelial growth factor (VEGF) and basic fibroblast growth factor (FGF-2) exhibits potent anti-angiogenic effects.
    Li D; Xie K; Zhang L; Yao X; Li H; Xu Q; Wang X; Jiang J; Fang J
    Cancer Lett; 2016 Jul; 377(2):164-73. PubMed ID: 27130666
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vascular endothelial growth factor and basic fibroblast growth factor present in Kaposi's sarcoma (KS) are induced by inflammatory cytokines and synergize to promote vascular permeability and KS lesion development.
    Samaniego F; Markham PD; Gendelman R; Watanabe Y; Kao V; Kowalski K; Sonnabend JA; Pintus A; Gallo RC; Ensoli B
    Am J Pathol; 1998 Jun; 152(6):1433-43. PubMed ID: 9626048
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatocyte growth factor stimulated angiogenesis without inflammation: differential actions between hepatocyte growth factor, vascular endothelial growth factor and basic fibroblast growth factor.
    Kaga T; Kawano H; Sakaguchi M; Nakazawa T; Taniyama Y; Morishita R
    Vascul Pharmacol; 2012 Aug; 57(1):3-9. PubMed ID: 22361334
    [TBL] [Abstract][Full Text] [Related]  

  • 35. miR-181a Targets RGS16 to Promote Chondrosarcoma Growth, Angiogenesis, and Metastasis.
    Sun X; Charbonneau C; Wei L; Chen Q; Terek RM
    Mol Cancer Res; 2015 Sep; 13(9):1347-57. PubMed ID: 26013170
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Interleukin-6 induced basic fibroblast growth factor-dependent angiogenesis in basal cell carcinoma cell line via JAK/STAT3 and PI3-kinase/Akt pathways.
    Jee SH; Chu CY; Chiu HC; Huang YL; Tsai WL; Liao YH; Kuo ML
    J Invest Dermatol; 2004 Dec; 123(6):1169-75. PubMed ID: 15610530
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Protein kinase D2 is a crucial regulator of tumour cell-endothelial cell communication in gastrointestinal tumours.
    Azoitei N; Pusapati GV; Kleger A; Möller P; Küfer R; Genze F; Wagner M; van Lint J; Carmeliet P; Adler G; Seufferlein T
    Gut; 2010 Oct; 59(10):1316-30. PubMed ID: 20732914
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HSulf-1 inhibits angiogenesis and tumorigenesis in vivo.
    Narita K; Staub J; Chien J; Meyer K; Bauer M; Friedl A; Ramakrishnan S; Shridhar V
    Cancer Res; 2006 Jun; 66(12):6025-32. PubMed ID: 16778174
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antiangiogenic mechanisms of PJ-8, a novel inhibitor of vascular endothelial growth factor receptor signaling.
    Huang SW; Lien JC; Kuo SC; Huang TF
    Carcinogenesis; 2012 May; 33(5):1022-30. PubMed ID: 22436611
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Kallistatin, a novel anti-angiogenesis agent, inhibits angiogenesis via inhibition of the NF-κB signaling pathway.
    Huang KF; Huang XP; Xiao GQ; Yang HY; Lin JS; Diao Y
    Biomed Pharmacother; 2014 May; 68(4):455-61. PubMed ID: 24721321
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 38.